Join to access to all OVN content. Join for Free
Why Medical Affairs Needs More Leadership
Medical Affairs Leadership Leadership Development Patient-Centric Leadership Oncology Field Medical Leadership Training

Why Medical Affairs Needs More Leadership


Share This Article


Summary

In this episode, Scott Conry joins Tom Caravela to delve into the nuances of leadership within medical affairs. Scott shares his extensive experiences and challenges faced in leadership roles, offering insights into the development of essential leadership skills and building trust. The discussion covers tips for emerging leaders, the differences between in-house and outsourced leadership training, and fostering a leadership culture. Scott reflects on his journey, lessons learned from mistakes, and evolving trends in the field, emphasizing patient-centric leadership. The episode wraps up with closing thoughts and a preview of the next episode.

Today’s guest is Scott Conry, Vice President, Head Oncology Field Medical at GSK discusses why Medical Affairs needs more leadership.

Scott shares….

👉 What it takes to be a great leader
👉 Why there is a need for companies to develop people
👉 What people need to do to stand out and position themselves for growth 
👉 How GOOD leaders unlock the potential of their team
👉 Thoughts on outsourcing leadership development
👉 What medical affairs needs to do to evolve

Click for Source
Medical Affairs Leadership, Leadership Development, Patient-Centric Leadership, Oncology Field Medical, Leadership Training

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Medical affairs: The power behind redefining commercialization
Partner Avatar Envision Pharma Group

Medical affairs: The power behind redefining commercialization

Podcast
Soft Skills & Leadership Advice for Introverts: In an Extrovert World
Partner Avatar MSL Talk: Tom Caravela, Josh Kosnick

Soft Skills & Leadership Advice for Introverts: In an Extrovert World

Podcast
Emotional Intelligence and the MSL: More Important than EVER
Partner Avatar MSL Talk: Tom Caravela, Doug Yau

Emotional Intelligence and the MSL: More Important than EVER

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Explore OVN